FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 2040865 · Received March 24, 2011

Report

Report Number
9612164-2011-00110
Event Type
Injury
Date Received
March 24, 2011
Date of Event
February 15, 2011
Report Date
March 2, 2011
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION RESULTS: GI BLEED. EVALUATION CONCLUSION: NO CONCLUSION CAN BE DRAWN. BASED ON THE INFO PROVIDED NO ROOT CAUSE CAN BE DETERMINED.

Description of Event or Problem · 1

PT HAD TWO ENDEAVOR SPRINT RX DRUG ELUTING STENTS IMPLANTED TO THE PROXIMAL RCA. APPROX 3 WEEKS POST INDEX PROCEDURE, THE PT SUFFERED A GI BLEED. THE FOLLOWING WAS REPORTED: H/O APICAL THROMBUS ON COUMADIN FOR 3 MONTHS ONLY. C/O WEAKNESS, TARRY STOOLS HG 8.3, INR 1.7 ADMITTED TO HOSP. S/P COLON-NO BLEED, S/P UGI-BLEEDING AT DUODENUM. TWO UNITS OF PRBC, PLAVIX HELD X 2. DC HOME STABLE. PT WAS HOSPITALIZED FOR 6 DAYS AND TREATED WITH A PRBC TRANSFUSION. PT WAS ALSO REPORTED TO HAVE UNDERGONE A POLYPECTOMY DURING HOSPITALIZATION. THE INVESTIGATOR REPORTS THAT THE GI BLEED WAS NOT RELATED TO THE STUDY STENT/ PROCEDURE, BUT WAS PROBABLY RELATED TO THE ANTIPLATELET STUDY DRUG. IT IS REPORTED THAT THE PT RECOVERED WITH TREATMENT. (REF MFR #9612164-2011-00109).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC IRELAND NA UNK

Patients

Seq Age Sex Outcome Treatment
1 67 YR Hospitalization| R AND PRASUGREL AT TIME OF EVENT| CLOPIDOGREL| PATIENT WAS ON ASPIRIN